Liver enzyme measuring hepatocellular damage and liver cell integrity.
Non-Alcoholic Fatty Liver Disease (NAFLD) / NASH
Non-alcoholic fatty liver disease (NAFLD) is a build-up of fat in the liver that is not caused by heavy drinking. The terminology changed in 2023: metabolic dysfunction-associated steatotic liver disease (MASLD) describes liver fat together with at least one cardiometabolic risk factor, and MASH describes the inflammatory form. It is closely linked to insulin resistance, excess weight around the waist, type 2 diabetes and high triglycerides. Most people have simple fatty liver, which causes no symptoms. In some, the fat triggers inflammation (NASH/MASH) that can lead to scarring (fibrosis) and, over years, cirrhosis.
Lab tests linked to NAFLD/NASH:
- ALT and AST: liver enzymes that are often mildly raised but can be normal.
- AST/ALT ratio: in fatty liver, ALT is usually higher than AST. A rising ratio can be a sign of more advanced scarring, and it is also seen with alcohol-related liver disease.
- Fasting insulin, HOMA-IR and LP-IR score: measures of insulin resistance, the main driver of fatty liver.
- VLDL cholesterol: often raised, reflecting the liver's extra fat output.
- Doctors may also order a platelet count to calculate a FIB-4 score, an ultrasound, and a liver stiffness scan (elastography).
How results are read:
- Normal liver enzymes do not rule out fatty liver or scarring.
- Blood tests can't measure liver fat. Fat is seen on imaging, and scores such as FIB-4 combined with elastography estimate the risk of scarring.
- Other causes of liver fat or raised enzymes, such as alcohol, viral hepatitis and some medicines, are ruled out first.
When to see a doctor:
- See a doctor to assess your scarring risk if you have type 2 diabetes, obesity or raised liver enzymes.
- Get emergency care for vomiting blood, black tarry stools or new confusion. Get urgent medical assessment for new yellowing of the skin or eyes, or a swollen abdomen.
Clinical takeaway: fatty liver is found on imaging and linked to insulin resistance, and the main question for health is how much scarring is present, which FIB-4 and elastography help estimate.
Biomarkers related to this condition
9 markers commonly used to screen, diagnose, or monitor Non-Alcoholic Fatty Liver Disease (NAFLD) / NASH
Liver and muscle enzyme released when cells are injured.
Calculated ratio of AST to ALT liver enzymes — also called the De Ritis ratio
Liver enzyme
Homeostatic Model Assessment for Insulin Resistance
Measures baseline insulin concentration in fasting blood.
Lipoprotein-based insulin resistance score via NMR spectroscopy.
Fats for Energy Storage
Cholesterol inside VLDL, the particles that carry triglycerides.